<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fatty acid synthase (FASN) plays an important role in energy metabolism of fatty acids and is overexpressed in some <z:hpo ids='HP_0003003'>colon cancers</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated whether associations between body mass index (BMI) and risk of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> varied according to FASN expression </plain></SENT>
<SENT sid="2" pm="."><plain>During follow-up of 109,051 women in the ongoing prospective Nurses' Health Study, a total of 1351 incident colon and <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancers</z:e> were diagnosed between 1986 and 2004 </plain></SENT>
<SENT sid="3" pm="."><plain>We constructed tissue microarrays of the available resected <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> samples (n = 536), and FASN expression was analyzed by immunohistochemistry </plain></SENT>
<SENT sid="4" pm="."><plain>Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated using Cox proportional hazards regression models </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> statistical tests were two-sided </plain></SENT>
<SENT sid="6" pm="."><plain>High BMI was associated with an increased risk of FASN-negative (no or weak expression) <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> compared with <z:mpath ids='MPATH_458'>normal</z:mpath> BMI (high BMI [â‰¥ 30 kg/m(2)], ie, <z:mp ids='MP_0001261'>obese</z:mp> vs <z:mpath ids='MPATH_458'>normal</z:mpath> BMI [18.5-22.9 kg/m(2)], HR = 2.25, 95% CI = 1.49 to 3.40, P(trend) &lt; .001) but not with FASN-positive (moderate to strong expression) <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>A statistically significant <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> risks was observed between FASN-negative and FASN-positive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> (P(<z:hpo ids='HP_0001425'>heterogeneity</z:hpo>) = .033) </plain></SENT>
<SENT sid="8" pm="."><plain>The age-adjusted incidence rates for FASN-positive and FASN-negative <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> were 10.9 and 7.1, respectively, per 100,000 person-years </plain></SENT>
<SENT sid="9" pm="."><plain>This molecular pathological epidemiology study supports a role of energy metabolism in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> pathogenesis </plain></SENT>
</text></document>